R01 CA179120-01A1 : MicroRNAs: Safe and effective therapeutic adjuvants for treating triple negative breast cancers.

Funding Agency: NIH/NCI

Title: R01 CA179120-01A1 : MicroRNAs: Safe and effective therapeutic adjuvants for treating triple negative breast cancers.

Status: Active

Period: 02/2015-01/2020

Role: Principal Investigator

Grant Detail: To test the hypothesis that miRNAs are effect therapeutic adjuvants to treat drug resistant triple negative breast cancers.